Adult acute lymphocytic leukemia. Future research directions.
This article reviews future research of potential benefit to adults with acute lymphocytic leukemia (ALL). This new research includes dose intensive anthracyclines, novel agents, STI571 for Philadelphia chromosome-positive ALL, and risk-oriented strategies.